These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2072463)

  • 1. Identification of a uniquely immunodominant, cross-reacting site in the human immunodeficiency virus endonuclease protein.
    Björling E; Utter G; Stålhandske P; Norrby E; Chiodi F
    J Virol; 1991 Aug; 65(8):4543-6. PubMed ID: 2072463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
    Madaule P; Gairin JE; Bénichou S; Rossier J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine characterization of the antigenic site within the flap region in the protease protein of HIV-1.
    Ehnlund M; Björling E
    Arch Virol; 2000; 145(2):365-9. PubMed ID: 10752558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples.
    van Binsbergen J; Keur W; vd Graaf M; Siebelink A; Jacobs A; de Rijk D; Toonen J; Zekeng L; Afane Ze E; Gürtler LG
    J Virol Methods; 1997 Dec; 69(1-2):29-37. PubMed ID: 9504748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.
    Horal P; Svennerholm B; Jeansson S; Rymo L; Hall WW; Vahlne A
    J Virol; 1991 May; 65(5):2718-23. PubMed ID: 1707985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response.
    Zhang PF; Bouma P; Park EJ; Margolick JB; Robinson JE; Zolla-Pazner S; Flora MN; Quinnan GV
    J Virol; 2002 Jan; 76(2):644-55. PubMed ID: 11752155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to six synthetic peptides of capsid protein with sera from HIV-1 infected individuals.
    Liu G; Yang L; Wang J; Zhang G; Chen X; Zheng Y
    Cell Mol Immunol; 2005 Aug; 2(4):289-93. PubMed ID: 16274627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17.
    Zimmerman DH; Ulrich JT; Wright C; Lloyd JP; Winship MD; Sarin PS
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):741-9. PubMed ID: 9643374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic and immunogenic sites of HIV-2 glycoproteins.
    Chiodi F; Björling E; Samuelsson A; Norrby E
    Chem Immunol; 1993; 56():61-77. PubMed ID: 8452654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.
    zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW
    J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
    Liu H; Wu X; Xiao H; Conway JA; Kappes JC
    J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
    Liu X; Ota A; Watanabe M; Ueda S; Saitoh A; Shinagawa H; Nakata A; Kurimura T; Wang X; Zhao Y
    Microbiol Immunol; 1995; 39(10):775-85. PubMed ID: 8577268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1.
    Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.
    Björling E; Broliden K; Bernardi D; Utter G; Thorstensson R; Chiodi F; Norrby E
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6082-6. PubMed ID: 2068087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.
    Böttiger B; Karlsson A; Andreasson PA; Nauclér A; Costa CM; Norrby E; Biberfeld G
    J Virol; 1990 Jul; 64(7):3492-9. PubMed ID: 2191152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus.
    Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibody response to the HIV-1 specific "out" (vpu) protein: identification of an immunodominant epitope and correlation of antibody detectability to clinical stages.
    Schneider T; Hildebrandt P; Rönspeck W; Weigelt W; Pauli G
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):943-50. PubMed ID: 1697179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.